Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 16 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 16 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 21 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 21 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

Synthetic DNA Studied for Mass Data Storage

DNA illustration

An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage

Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

Global venture capital investing

Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector. . . . → Read More: Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot

UPMC to Invest $1 Billion in Medical Enterprises

UPMC lab

UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises

Algorithm-Designed Robots Made from Living Cells

Manufactured organism

A team of biologists and computer scientists created tiny robotic devices designed by computer models and made from frog embryo cells. . . . → Read More: Algorithm-Designed Robots Made from Living Cells

Venture Philanthropy Funds Rare Neuro Disease Trial

Neurons illustration

A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials. . . . → Read More: Venture Philanthropy Funds Rare Neuro Disease Trial

New Biotech Aims to Bring Down Drug Prices

Pills on money

A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs. . . . → Read More: New Biotech Aims to Bring Down Drug Prices

Infographic – High Momentum Start-Ups to Watch

Game Changers 2020

The list of 36 companies covers 12 technology categories, including many of the advances we feature at Science & Enterprise . . . → Read More: Infographic – High Momentum Start-Ups to Watch

Pharma Gains Fibrosis Technology in $1B+ Deal

Stuart Cook

Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Trial Underway Testing Crispr-Based Antibiotic

E. coli

A clinical trial is recruiting participants to test an antibiotic made with engineered viruses, in people threatened with urinary tract infections from E. coli bacteria. . . . → Read More: Trial Underway Testing Crispr-Based Antibiotic